Ixico Plc Company Profile (LON:IXI)

Analyst Ratings

Consensus Ratings for Ixico Plc (LON:IXI) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Ixico Plc (LON:IXI)
Show:
DateFirmActionRatingPrice TargetActions
11/27/2014Daniel Stewart & CoReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/23/2014 forward)

Earnings

Earnings History for Ixico Plc (LON:IXI)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Ixico Plc (LON:IXI)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Ixico Plc (LON:IXI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Ixico Plc (LON:IXI)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
3/1/2016Lowther,SusanInsiderBuy28,366GBX 35£9,928.10Tweet This Trade  Share This Trade on StockTwits
2/4/2016Hill,DerekInsiderBuy10,000GBX 39£3,900Tweet This Trade  Share This Trade on StockTwits
2/3/2016Richards,AndrewInsiderBuy45,899GBX 33£15,146.67Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Ixico Plc (LON:IXI)
DateHeadline
06/07/16 07:19 AMIxico Focused On Delivering On New Contracts As Interim Loss Widens
06/07/16 06:07 AMHalf Year 2016 IXICO PLC Earnings Release - Before Market Open -
06/07/16 01:18 AMIXICO's Half Yearly Report to 31 March 2016 - [at noodls] - Continued expansion of digital technologies and therapeutic areas focused on brain health Delivering on new contracts including Parkinson's disease and multiple sclerosis Period Highlights • Assessa® partnership ...
06/02/16 01:15 AMReal World Digital Data Collection Study, Project Cygnus, Joins Dementias Platform UK - [at noodls] - The four NHS Trusts participating in the project have now initiated enrolment in the mehealth® digital technology platform which is being deployed for data collection and management. Consumer wearable ...
05/18/16 04:32 AMOptimal Medicine Inc. Renamed IXICO Technologies Inc. - [at noodls] - 18 May 2016 IXICO plc (Ticker: IXI) ('IXICO' or the 'Company'), the brain health company, is pleased to announce that Optimal Medicine Inc. has been renamed IXICO Technologies Inc. with immediate effect. ...
05/05/16 11:11 AMIXICO Announces Annual Meeting of Project Advancing Technological, Clinical and Regulatory Agendas in Cognitive Impairment - [at noodls] - IXICO is pleased to announce that the Cygnus Project Annual Meeting will be held on Friday 6th May 2016 at Manchester City Labs. Leading experts in dementia research and clinical care, including Alistair ...
05/05/16 06:53 AMIXICO : MyBrainBook® Selected as Runner-up for Medilink UK Partnership with NHS Award - IXICO plc are pleased to announce that MyBrainBook®, its digital support platform for people with dementia and their carers, has been selected as Runner-up for the Medilink UK - Partnership with the NHS Award. The award which was announced as part of the ...
05/05/16 03:41 AMMyBrainBook® Selected as Runner-up for Medilink UK Partnership with NHS Award - [at noodls] - IXICO plc are pleased to announce that MyBrainBook®, its digital support platform for people with dementia and their carers, has been selected as Runner-up for the Medilink UK - Partnership with the NHS ...
04/16/16 06:47 AMClinical Trials Imaging Market to See a 6.2% CAGR to 2020 Driven by Growth in Pharmaceutical & Biotechnology Industries - The major players in this market include BioClinica, Inc. (U.S.), Biomedical Systems (U.S.), Cardiovascular Imaging Technologies (U.S.), ICON Public Limited Company (Ireland), Intrinsic Imaging, LLC (U.S.), IXICO, PLC (U.K.), PAREXEL International ...
04/07/16 06:30 AMImperial Innovations Portfolio Value Rises, First Half Loss Narrows - Oxford Immunotec Global PLC and Ixico PLC, and was valued at GBP100.0 million at the end of the half year, down from GBP106.8 million at the end of July. Imperial Innovations said it remains confident that there is potential for a number of companies from ...
04/04/16 03:41 PMIXICO PLC to support clinical trials for Parkinson's drug - Brain health company IXICO Plc (LON:IXI) has been awarded a contract by Oxford Biomedica to support clinical trials of a new treatment for Parkinson’s disease. The study, expected to start by the middle of this year, will see Ixico support the use of ...
04/04/16 06:23 AMNorthland Capital Partners View on the City - W Resources, Sunrise Resources, IXICO - Following the issue the Company will have 864,363,659 shares in issue. IXICO Plc (LON:IXI): New five year contract, joins consortium Market Cap: £10.3m; Current Price: 39p IXICO was awarded a new five year contract and the group has joined a consortium ...
04/04/16 06:23 AMIXICO : strengthens position in Parkinson’s disease clinical trials - 4 April 2016, IXICO plc (Ticker: IXI) ('IXICO' or the 'Company'), the brain health company, today announces two further milestones in its growing Parkinson's disease franchise. IXICO has joined seven global pharmaceutical companies including: AbbVie ...
04/04/16 01:52 AMIXICO strengthens position in Parkinson’s disease clinical trials - [at noodls] - Joins ground breaking consortium and awarded five year contract Read full press release here 4 April 2016, IXICO plc (Ticker: IXI) ('IXICO' or the 'Company'), the brain health company, today announces ...
03/31/16 06:12 AMReal world study of Digital Biomarkers - 31 March 2016, IXICO plc (Ticker: IXI) ('IXICO' or the 'Company'), the brain health company, today announces that John Hall, IXICO's SVP Commercial Operations, and Ken Tubman, IXICO's VP Health Technology, are delivering a presentation on Digital ...
03/31/16 01:16 AMIXICO announces its real world study of Digital Biomarkers in people with dementia - [at noodls] - Download press release here 31 March 2016, IXICO plc (Ticker: IXI) ('IXICO' or the 'Company'), the brain health company, today announces that John Hall, IXICO's SVP Commercial Operations, and Ken Tubman, ...
03/30/16 06:15 AMIXICO : Wins NHS Urgent And Emergency Care Platform Contract - LONDON (Alliance News) - Brain health company IXICO PLC on Wednesday said it has secured a development deal with SBRI Healthcare, covering further development and integration of its MyBrainBook platform with UK National Health Service urgent and emergency ...
03/30/16 06:15 AMNorthland Capital Partners View on the City: James Latham and IXICO plc - Revenue for the full year to March 2016 is expected to be broadly in line with our forecasts (£187m) and profit before tax (PBT) is likely to be higher than our forecasts (£11m) for FY16, which indicates the operating margin improvement experienced ...
03/30/16 01:14 AMIXICO announces NHS emergency and out-of-hours services development contract - [at noodls] - Building on previous work, this initiative will provide urgent and emergency care services including 111 and GP out-of-hours services with real-time access to a combination of clinical, social care and ...
03/03/16 05:35 AMNorthland Capital Partners View on the City - Amphion Innovations, W resources, Ixico - We believe that the group’s significant stakes in both Motif Bio plc and Kromek Group plc ... to Régua there is clearly the potential for synergistic benefits. IXICO announced that its mehealth® technology has been deployed by the American Academy ...
03/03/16 05:35 AMMehealth used in American Academy of Pediatrics - Improving pediatric care for children with ADHD in the US 3 March 2016, IXICO plc (Ticker: IXI) ('IXICO' or the 'Company'), the brain health company, is pleased to announce that its mehealth® technology has been deployed by the American Academy of ...
03/03/16 05:35 AMIXICO : Says Mehealth Technology Used By American Academy Of Pediatrics - LONDON (Alliance News) - Brain health company IXICO PLC on Thursday said its 'mehealth' technology was used by the American Academy of Pediatrics as part of an improvement programme. The American Academy of Pediatrics' 2016 quality improvement programme is ...
03/01/16 02:30 PMDIRECTOR DEALINGS: IXICO Chief Financial Officer Buys First Shares - LONDON (Alliance News) - IXICO PLC said Chief Financial Officer Susan Lowther bought 28,366 shares at a price of 35.25 pence per share Tuesday. The purchase is her only holding in the brain health company. The stock was flat at 35.25p Tuesday.
03/01/16 05:32 AMClinical Trials Imaging Market worth 981.53 Million USD by 2020 - The major players in this market include BioClinica, Inc. (U.S.), Biomedical Systems (U.S.), Cardiovascular Imaging Technologies (U.S.), ICON Public Limited Company (Ireland), Intrinsic Imaging, LLC (U.S.), IXICO, PLC (U.K.), PAREXEL International ...
01/29/16 06:09 AMIXICO's AGM Results - [at noodls] - Enquiries IXICO plc Derek Hill, CEO Susan Lowther, CFO +44 20 3763 7499 Peel Hunt LLP (Nominated Adviser and Broker) James Steel / Oliver Jackson +44 20 7418 8900 Daniel Stewart & Company (Joint Broker) ...
01/29/16 01:14 AMIXICO's AGM Statement and Board Changes - [at noodls] - At the meeting Dr Andrew Richards, the Company's Chairman will make the following statement: 'I am pleased to report a strong performance in the year ended 30 September 2015 and that this momentum has ...
01/29/16 01:14 AMIXICO's AGM Statement - [at noodls] - At the meeting Dr Andrew Richards, the Company's Chairman will make the following statement: 'I am pleased to report a strong performance in the year ended 30 September 2015 and that this momentum has ...
01/22/16 03:43 AMIXICO selected to participate in two NHS Innovation Test Beds - [at noodls] - The Test Beds are seven new collaborations between the NHS and innovators which aim to harness technology to address some of the most complex issues facing patients and the health service. Successful innovations ...
01/21/16 04:15 AMIXICO’s MyBrainBook wins Regional Business Award for Partnership with the NHS - [at noodls] - MyBrainBook® has been developed in collaboration with the Health Innovation Network (Academic Health Science Network for South London), Mental Health Trusts, community care providers and 3rd sector partners ...
01/18/16 08:11 AMIxico wins four new contracts worth over £3m -
01/18/16 02:22 AMIXICO awarded four contracts worth a combined value of over £3.0m - [at noodls] - Further cements IXICO's partnerships with leading pharmaceutical and biotechnology companies developing drugs for Alzheimer's disease. 18 January 2016, IXICO plc (Ticker: IXI) ('IXICO' or the 'Company'), ...
01/07/16 06:07 AMFull Year 2015 IXICO PLC Earnings Release - Before Market Open -
01/07/16 03:28 AMIXICO Financial Results - Year Ended 30 September 2015 - [at noodls] - Long term contract award of Phase II/III global study in neurodegenerative disease o Contract from leading global pharmaceutical company o Highlights growing position in neuroscience clinical trial market ...
01/07/16 02:18 AMFinancial Results for the year ended 30 Sept 2015 - [at noodls] - 7 January 2016 Financial Results for the year ended 30 September 2015 Executing the digital healthcare strategy IXICO plc (AIM: IXI) ('IXICO' or the 'Company'), the brain health company, today announces ...
12/23/15 08:19 AMIXICO Selected as Finalist in SEHTA Healthcare Business Awards - [at noodls] - We are excited to announce that IXICO has been selected as one of two finalists for the SEHTA Healthcare Business Awards in the 'Partnership with the NHS' category for MyBrainBook - a partnership project ...
12/21/15 10:09 AMUpdate on Issued Share Capital - [at noodls] - 21 December 2015 IXICO PLC('IXICO' or the 'Company') 21 December 2015: Further to the completion of the acquisition of Optimal Medicine on 8 December 2015 IXICO plc (AIM: IXI) today announces that one ...
12/08/15 04:55 AMIXICO Shortlisted for KSS AHSN Expo Award - [at noodls] - We are excited to announce that IXICO has been shortlisted for the Kent Surrey Sussex Academic Health Science Network (KSS AHSN) 2016 Awards, in the 'Enhancing Innovation through Collaboration' category. ...

Social

About Ixico Plc

Ixico Plc logoIXICO plc is engaged in the provision of clinical trials services to the pharmaceutical industry. The Company provides its technologies to those involved in researching and treating diseases, such as dementia. The Company's digital health technology consists of three product platforms, which include TrialTracker, Assessa and MyBrainBook. Its TrialTracker image data and query management platform serves its clinical trials business. TrialTracker is used in clinical trials run by IXICO and forms the framework for its medical device, Assessa. The Company's Assessa is its decision support tool for diagnosing dementia and Alzheimer's disease. Assessa is also used in other neurological disorders in which the measurement of hippocampal volume can be used, such as schizophrenia. Its MyBrainBook provides support to dementia patients post-diagnosis. MyBrainBook is a digital health hub delivering facilitated support to patients and their carers.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: IXI
  • CUSIP:
Key Metrics:
  • Previous Close: $0.41
  • 50 Day Moving Average: $33.95
  • 200 Day Moving Average: $35.87
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $7.12M
  • Current Year EPS Consensus Estimate: $-4.10 EPS
  • Next Year EPS Consensus Estimate: $N/A EPS
Additional Links: